FDS Amplicare Description

FDS Amplicare, now integrated with EnlivenHealth™, enhances the well-being of pharmacies and their clientele. By offering cutting-edge software solutions and services, we facilitate the advancement of the clinically oriented New Era Pharmacy, allowing our clients to deliver thorough pharmacy and clinical care services within their communities. Presently, over 40,000 retail pharmacies across the nation utilize the technology solutions provided by EnlivenHealth™/FDS Amplicare. EnlivenHealth™ operates as a subsidiary of Omnicell, Inc. (Nasdaq: OMCL), which stands as a prominent provider of medication management solutions and adherence tools tailored for healthcare systems and pharmacies. Our commitment to innovation continues to drive better health outcomes for both pharmacies and their patients.

Integrations

Reviews - 1 Verified Review

Total 1 out of 5 stars
ease 1 out of 5 stars
features 1 out of 5 stars
design 1 out of 5 stars
support 1 out of 5 stars

Company Details

Company:
EnlivenHealth
Headquarters:
United States
Website:
fdsrx.com

Media

FDS Amplicare Screenshot 1
Recommended Products
Earn up to 16% annual interest with Nexo. Icon
Earn up to 16% annual interest with Nexo.

Access competitive interest rates on your digital assets.

Generate interest, borrow against your crypto, and trade a range of cryptocurrencies — all in one platform. Geographic restrictions, eligibility, and terms apply.
Get started with Nexo.

Product Details

Platforms
Web-Based
Types of Training
Training Docs
Live Training (Online)
Webinars
In Person
Customer Support
Business Hours
Online Support

FDS Amplicare Features and Options

Pharmacy Software

Claims Management
E-Prescribing
Electronic Signature
Forms Management

FDS Amplicare User Reviews

Write a Review
  • Name: Steve K.
    Job Title: Owner
    Length of product use: 2+ Years
    Used How Often?: Daily
    Role: User
    Organization Size: 1 - 25
    Features 1 out of 5 stars
    Design 1 out of 5 stars
    Ease 1 out of 5 stars
    Pricing 1 out of 5 stars
    Support 1 out of 5 stars
    Likelihood to Recommend to Others 1 out of 10

    Was good 2022 and prior now Garbage

    1 out of 5 stars Date: Oct 19 2023

    Summary: I can no longer recommend this product that we have used for the last 8 years. No warning that this would change can no longer get an idea of what we will be paying in DIR fees and what we will be reimbursed for the product. Making us completely blind, and the patient can no longer get clear and informative information as they had before.

    Positive: Was easy to use.
    Pulled the drugs we filled for the patient.
    Sometimes could pull the patient's insurance to help with the comparison.
    Quick and easy.

    Negative: Now changed can't even sort the plans.
    Can't clearly see what the plan costs and what each drug will cost.
    Total waste of time and money.

    Read More...
  • Previous
  • You're on page 1
  • Next